Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives $37.67 Average Target Price from Analysts
Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, four have given a buy recommendation and […]
13 Aug 06:34 · The Markets Daily